Issue 57, 2021

Imidazolium labelling permits the sensitive mass-spectrometric detection of N-glycosides directly from serum

Abstract

A novel imidazolium derivative (GITag) shows superior ionisation and consequently allows increased mass spectrometric detection capabilities of oligosaccharides and N-glycans. Here we demonstrate that human serum samples can be directly labelled by GITag on a MALDI target plate, abrogating prevalently required sample pretreatment or clean-up steps.

Graphical abstract: Imidazolium labelling permits the sensitive mass-spectrometric detection of N-glycosides directly from serum

Supplementary files

Article information

Article type
Communication
Submitted
20 Apr 2021
Accepted
17 Jun 2021
First published
17 Jun 2021
This article is Open Access
Creative Commons BY license

Chem. Commun., 2021,57, 7003-7006

Imidazolium labelling permits the sensitive mass-spectrometric detection of N-glycosides directly from serum

Y. Zhang, M. Ghirardello, T. Wang, A. Lu, L. Liu, J. Voglmeir and M. C. Galan, Chem. Commun., 2021, 57, 7003 DOI: 10.1039/D1CC02100A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements